<DOC>
	<DOCNO>NCT01484600</DOCNO>
	<brief_summary>This study Safety , Tolerability , Pharmacokinetics , Immunogenicity REGN668 Administered Subcutaneously Healthy Volunteers .</brief_summary>
	<brief_title>Study Safety , Tolerability , Pharmacokinetics , Immunogenicity REGN668 Administered Subcutaneously Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Male female subject 18 55 year age . 2 . Body weight 60 kg 80 kg , body mass index 20 30 kg/m2 inclusive . 3 . NHV evidence comprehensive clinical assessment ( detailed medical history complete physical examination ) . 4 . Normal rest blood pressure heart rate 5 . Willingness refrain consumption alcohol 24 hour prior study visit . 1 . History presence currently relevant medical condition , include cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , hematological , neurological , musculoskeletal , psychiatric , systemic , ocular , infectious parasitic disease , sign acute illness . 2 . Administration medication within 1 week randomization , vitamin , nutritional supplement , low dos aspirin take prophylactically . 3 . Onset new exercise routine major change previous exercise routine within 2 week prior randomization . Subjects must willing maintain relatively constant level exercise study refrain unusually strenuous physical activity 4 . Known history human immunodeficiency virus ( HIV ) antibody ; and/or positive hepatitis B surface antigen ( HBsAg ) , and/or positive hepatitis C antibody ( HCV ) screen visit . 5 . History substance ( eg . drug alcohol ) abuse regular ( daily ) smoking within year prior randomization positive result urine drug screen . 6 . Excessive consumption beverage xanthine derivates ( caffeine , theophylline , theobromine ) , coffee , tea , cola , yerba mate ( 4 cup glass per day ) . 7 . Hospitalization reason within 60 day randomization . 8 . Participation clinical research study evaluate another investigational drug therapy within 30 day investigational drug , whichever longer , prior randomization visit . 9 . Live/attenuated vaccination within 12 week randomization study . 10 . Tuberculosis vaccination within last year . 11 . Previous exposure biological agent within 12 month randomization . 12 . History hypersensitivity reaction doxycycline tetracycline . 13 . Recent travel ( within 12 month randomization ) area endemic parasitic helminthes , develop country , particularly Africa tropical subtropical region Asia . 14 . Pregnant breastfeed woman . 15 . Unwilling use adequate birth control reproductive potential sexually active</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Volunteers</keyword>
</DOC>